Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
about
Myeloid malignancies: mutations, models and managementThe role of suppressors of cytokine signalling in human neoplasmsDecitabine in the treatment of myelodysplastic syndromes.A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies.Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemiaThe role of Janus kinases in haemopoiesis and haematological malignancy.MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.The rationale and use of hypomethylation agents in adult acute myeloid leukemia.miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia.Epigenetic alterations of p15(INK4B) and p16(INK4A) genes in pediatric primary myelodysplastic syndrome.miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cellsEpigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features.Clinical implications of SOCS1 methylation in myelodysplastic syndrome.
P2860
Q27000577-1C1E5C90-FF6B-41FC-AE98-1BB0E0E3A3F6Q27026783-6F3FD931-2C74-48EC-AF3A-96011298449EQ34088403-EE212799-EE82-4EB1-AE3F-0106CC6249EEQ36216230-41FE6A33-40AE-4C0B-844B-20075557F3D9Q36238674-A8B2FF81-0FCF-489A-93F8-4891229A587DQ36527760-11E5A19D-00EF-4401-84E2-F9C81680E044Q37396081-B6C1C0A4-285C-4B75-A97E-75EAC8DF91FBQ38088358-AA84648A-5BC1-47FE-89FB-CBD5143866AEQ38476564-195D7E14-402E-4768-9FB5-827712E56CA6Q38716306-87546095-0500-492B-9B5E-489A86E002C6Q38915689-FED91250-B4E4-4A77-AF27-A5AD753C1F0DQ39675914-E4F5B79E-3575-4F8F-91E1-164BAA42AA94Q41894298-28789DF7-755B-4BA8-B903-30071BFD04A2Q46719544-29A95E15-FE46-4673-985E-E09F4D2DDAA3Q53281416-789CD93A-D8C9-4A7D-8F29-31873098A9BEQ53830978-E740342F-E558-4548-9D33-2DD1E06C728BQ54580979-3B3FC208-8E5E-4D3E-9006-79C8B13A5003
P2860
Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hypermethylation of the suppre ...... ) in myelodysplastic syndrome.
@en
Hypermethylation of the suppressor of cytokine signalling-1
@nl
type
label
Hypermethylation of the suppre ...... ) in myelodysplastic syndrome.
@en
Hypermethylation of the suppressor of cytokine signalling-1
@nl
prefLabel
Hypermethylation of the suppre ...... ) in myelodysplastic syndrome.
@en
Hypermethylation of the suppressor of cytokine signalling-1
@nl
P2093
P2860
P1476
Hypermethylation of the suppre ...... ) in myelodysplastic syndrome.
@en
P2093
Brigitte Schlegelberger
Hans Kreipe
Kai Brakensiek
Ulrich Lehmann
P2860
P304
P356
10.1111/J.1365-2141.2005.05590.X
P407
P577
2005-07-01T00:00:00Z